BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,130 filers reported holding BAXTER INTL INC in Q1 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,462,642 | -15.6% | 489,206 | +1.9% | 0.17% | -23.3% |
| Q2 2023 | $21,883,235 | -18.7% | 480,317 | -27.6% | 0.22% | -10.2% |
| Q1 2023 | $26,908,630 | +547.1% | 663,428 | +1.2% | 0.24% | +2.5% |
| Q4 2022 | $4,158,377 | -77.1% | 655,576 | +94.0% | 0.24% | -40.1% |
| Q3 2022 | $18,196,000 | +3821.6% | 337,843 | +4574.1% | 0.40% | +4311.1% |
| Q2 2022 | $464,000 | +72.5% | 7,228 | +108.5% | 0.01% | +125.0% |
| Q1 2022 | $269,000 | -12.9% | 3,467 | -3.6% | 0.00% | -20.0% |
| Q4 2021 | $309,000 | +9.6% | 3,598 | +2.4% | 0.01% | +25.0% |
| Q3 2021 | $282,000 | +6.4% | 3,512 | +6.7% | 0.00% | 0.0% |
| Q2 2021 | $265,000 | +20.5% | 3,290 | +28.5% | 0.00% | -20.0% |
| Q2 2020 | $220,000 | -37.9% | 2,560 | -41.3% | 0.01% | -50.0% |
| Q1 2020 | $354,000 | -32.4% | 4,360 | -30.4% | 0.01% | -9.1% |
| Q4 2019 | $524,000 | -25.8% | 6,261 | -22.5% | 0.01% | -31.2% |
| Q3 2019 | $706,000 | +16.5% | 8,075 | +9.0% | 0.02% | +23.1% |
| Q2 2019 | $606,000 | -20.4% | 7,405 | -20.9% | 0.01% | -23.5% |
| Q1 2019 | $761,000 | +274.9% | 9,356 | +256.1% | 0.02% | +325.0% |
| Q3 2018 | $203,000 | -2.9% | 2,627 | -40.0% | 0.00% | -33.3% |
| Q3 2016 | $209,000 | -37.0% | 4,381 | -40.4% | 0.01% | -33.3% |
| Q2 2016 | $332,000 | 0.0% | 7,345 | -9.1% | 0.01% | 0.0% |
| Q1 2016 | $332,000 | +43.7% | 8,080 | +15.1% | 0.01% | +28.6% |
| Q3 2015 | $231,000 | -88.9% | 7,022 | -76.4% | 0.01% | -88.9% |
| Q2 2015 | $2,083,000 | +4.3% | 29,794 | +2.2% | 0.06% | +3.3% |
| Q1 2015 | $1,997,000 | -2.6% | 29,150 | +4.2% | 0.06% | -4.7% |
| Q4 2014 | $2,050,000 | +15.4% | 27,973 | +13.0% | 0.06% | +6.7% |
| Q3 2014 | $1,776,000 | -1.5% | 24,746 | -0.8% | 0.06% | -18.9% |
| Q2 2014 | $1,803,000 | +10.7% | 24,935 | +12.6% | 0.07% | +4.2% |
| Q1 2014 | $1,629,000 | +4.1% | 22,147 | -1.6% | 0.07% | 0.0% |
| Q4 2013 | $1,565,000 | -15.4% | 22,497 | -20.1% | 0.07% | -14.5% |
| Q3 2013 | $1,850,000 | -23.8% | 28,172 | -19.7% | 0.08% | -27.2% |
| Q2 2013 | $2,429,000 | – | 35,070 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |